NANOVIRICIDES, INC. Repayments of Convertible Debt
NANOVIRICIDES, INC. (NNVC) reported Repayments of Convertible Debt of $0 for the 12-month period ending 2019-06-30, per its 10-K filed 2019-08-23.
Discontinued › Cash Flow › Financing Activities
us-gaap:RepaymentsOfConvertibleDebt · last filed 2019-08-23
- NANOVIRICIDES, INC. repayments of convertible debt for the quarter ending 2018-06-30 was $0.00.
- NANOVIRICIDES, INC. repayments of convertible debt for the quarter ending 2017-06-30 was $0.00.
- NANOVIRICIDES, INC. repayments of convertible debt for the quarter ending 2016-06-30 was $0.00.
- NANOVIRICIDES, INC. repayments of convertible debt for fiscal 2019 was $0.00.
- NANOVIRICIDES, INC. repayments of convertible debt for fiscal 2018 was $0.00, a 100.00% decline from fiscal 2017.
- NANOVIRICIDES, INC. repayments of convertible debt for fiscal 2017 was $1.00M.
- NANOVIRICIDES, INC. repayments of convertible debt for fiscal 2016 was $0.00.
| Period end | Repayments of Convertible Debt 0 month | Repayments of Convertible Debt 1 month | Repayments of Convertible Debt 3 month | Repayments of Convertible Debt 9 month | Repayments of Convertible Debt 12 month |
|---|---|---|---|---|---|
| 2019-06-30 | $0.00 10-K · filed 2019-08-23 | ||||
| 2018-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-08-23 | $0.00 10-K · filed 2019-08-23 | |||
| 2018-03-31 | $0.00 10-Q · filed 2018-05-21 | ||||
| 2017-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-08-23 | $1.00M 10-K · filed 2019-08-23 | |||
| 2017-03-31 | $1.00M 10-Q · filed 2018-05-21 | ||||
| 2017-02-08 | $1.00M 10-Q · filed 2017-05-15 | $1.00M 10-K · filed 2019-08-23 | |||
| 2016-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-10-12 | $0.00 10-K · filed 2018-10-12 | |||
| 2016-03-31 | $0.00 10-Q · filed 2017-05-15 | ||||
| 2015-06-30 | $0.00 10-K · filed 2017-09-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |